These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25824408)

  • 1. Novel roles of ginsenoside Rg3 in apoptosis through downregulation of epidermal growth factor receptor.
    Joo EJ; Chun J; Ha YW; Ko HJ; Xu MY; Kim YS
    Chem Biol Interact; 2015 May; 233():25-34. PubMed ID: 25824408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rg3 Decreases NHE1 Expression via Inhibiting EGF-EGFR-ERK1/2-HIF-1
    Li X; Tsauo J; Geng C; Zhao H; Lei X; Li X
    Am J Chin Med; 2018; 46(8):1915-1931. PubMed ID: 30525897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rg3 regulates DNA damage in non-small cell lung cancer cells by activating VRK1/P53BP1 pathway.
    Liu T; Zuo L; Guo D; Chai X; Xu J; Cui Z; Wang Z; Hou C
    Biomed Pharmacother; 2019 Dec; 120():109483. PubMed ID: 31629252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.
    Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z
    Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenosides Inhibit the Proliferation of Lung Cancer Cells and Suppress the Rate of Metastasis by Modulating EGFR/VEGF Signaling Pathways.
    Yu X; Wang Q; Dai Z
    J Oleo Sci; 2024; 73(2):219-230. PubMed ID: 38311411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell.
    Xie Q; Wen H; Zhang Q; Zhou W; Lin X; Xie D; Liu Y
    Biomed Pharmacother; 2017 Jan; 85():16-21. PubMed ID: 27930981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling.
    Yang X; Zou J; Cai H; Huang X; Yang X; Guo D; Cao Y
    Biomed Pharmacother; 2017 Dec; 96():1240-1245. PubMed ID: 29169725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of 20(R)-ginsenoside Rg3 on the differential expression of cell signaling genes and other related genes in human lung adenocarcinoma cell line A549].
    Chen MW; Yang L; Ni L; Guo X; Tian RZ; Wang XQ
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):37-40. PubMed ID: 15774190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20(
    Liang Y; Zhang T; Jing S; Zuo P; Li T; Wang Y; Xing S; Zhang J; Wei Z
    Am J Chin Med; 2021; 49(3):753-765. PubMed ID: 33641655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
    Yuan Z; Jiang H; Zhu X; Liu X; Li J
    Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1.
    Li J; Qi Y
    Exp Mol Pathol; 2019 Feb; 106():131-138. PubMed ID: 30633886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Rg3 induces apoptosis in human multiple myeloma cells via the activation of Bcl-2-associated X protein.
    Luo Y; Zhang P; Zeng HQ; Lou SF; Wang DX
    Mol Med Rep; 2015 Sep; 12(3):3557-3562. PubMed ID: 25998024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune.
    Jiang Z; Yang Y; Yang Y; Zhang Y; Yue Z; Pan Z; Ren X
    Biomed Pharmacother; 2017 Dec; 96():378-383. PubMed ID: 29031195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
    Peng B; He R; Xu Q; Yang Y; Hu Q; Hou H; Liu X; Li J
    Pharmacol Res; 2019 Apr; 142():1-13. PubMed ID: 30735802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of caveolin-1 increased EGFR-TKIs sensitivity in lung adenocarcinoma cell line with EGFR mutation.
    Cui Y; Zhu T; Song X; Liu J; Liu S; Zhao R
    Biochem Biophys Res Commun; 2018 Jan; 495(1):733-739. PubMed ID: 29137977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of ginsenoside Rg3 on Pim-3 and Bad proteins in human pancreatic cancer cell line PANC-1].
    Jian J; Hu ZF; Huang Y
    Ai Zheng; 2009 May; 28(5):461-5. PubMed ID: 19624871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of metastatic ability and drug resistance in pulmonary adenocarcinoma by matrix rigidity via activating c-Met and EGFR.
    Chang CC; Hsieh TL; Tiong TY; Hsiao CH; Ji AT; Hsu WT; Lee OK; Ho JH
    Biomaterials; 2015 Aug; 60():141-50. PubMed ID: 26000960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inducement effect of ginsenoside Rg3 on apoptosis of human bladder transitional cell carcinoma cell line EJ].
    Chen JX; Peng HM; Pu SP; Guo YP
    Zhongguo Zhong Yao Za Zhi; 2007 Aug; 32(16):1680-4. PubMed ID: 18027667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
    Tian L; Shen D; Li X; Shan X; Wang X; Yan Q; Liu J
    Oncotarget; 2016 Jan; 7(2):1619-32. PubMed ID: 26636541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma.
    Zhou X; Guo J; Ji Y; Pan G; Liu T; Zhu H; Zhao J
    Mol Cancer Res; 2016 May; 14(5):448-57. PubMed ID: 26896556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.